相似文献
1
Renal function after percutaneous cryoablation of renal masses.
Radiol Bras. 2020 May-Jun;53(3):V-VI. doi: 10.1590/0100-3984.2020.53.3e1.
2
Safety and Efficacy of Percutaneous Image-guided Cryoablation of Completely Endophytic Renal Masses.
Urology. 2019 Nov;133:151-156. doi: 10.1016/j.urology.2019.08.005. Epub 2019 Aug 12.
3
Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses.
AJR Am J Roentgenol. 2008 Oct;191(4):1159-68. doi: 10.2214/AJR.07.3706.
4
Percutaneous and laparoscopic cryoablation of small renal masses.
J Urol. 2008 Aug;180(2):492-8; discussion 498. doi: 10.1016/j.juro.2008.04.019. Epub 2008 Jun 11.
5
Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.
J Endourol. 2010 Aug;24(8):1255-62. doi: 10.1089/end.2009.0328.
6
Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Eur Urol. 2019 Aug;76(2):244-251. doi: 10.1016/j.eururo.2019.04.026. Epub 2019 May 3.
7
Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Eur Urol. 2015 Feb;67(2):252-9. doi: 10.1016/j.eururo.2014.07.021. Epub 2014 Aug 6.
8
Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
J Vasc Interv Radiol. 2015 Jun;26(6):800-6. doi: 10.1016/j.jvir.2015.02.013. Epub 2015 Mar 31.
9
Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
BJU Int. 2012 Dec;110(11 Pt B):E526-31. doi: 10.1111/j.1464-410X.2012.11230.x. Epub 2012 May 15.
10
Percutaneous Ablation of T1 Renal Masses: Comparative Local Control and Complications after Radiofrequency and Cryoablation.
Diagnostics (Basel). 2023 Sep 26;13(19):3059. doi: 10.3390/diagnostics13193059.
引用本文的文献
1
Single-Probe Percutaneous Cryoablation with Liquid Nitrogen for the Treatment of T1a Renal Tumors.
Cancers (Basel). 2023 Oct 28;15(21):5192. doi: 10.3390/cancers15215192.
本文引用的文献
1
Early trends and predictors of renal function following computed tomography-guided percutaneous cryoablation of a renal mass in patients with and without prior renal impairment.
Radiol Bras. 2020 May-Jun;53(3):141-147. doi: 10.1590/0100-3984.2019.0098.
2
Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis.
Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1057-1069. doi: 10.2215/CJN.11941116. Epub 2017 May 8.
3
Renal Mass and Localized Renal Cancer: AUA Guideline.
J Urol. 2017 Sep;198(3):520-529. doi: 10.1016/j.juro.2017.04.100. Epub 2017 May 4.
4
The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System.
Urol Oncol. 2016 Nov;34(11):486.e1-486.e7. doi: 10.1016/j.urolonc.2016.05.025. Epub 2016 Jun 22.
5
Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.
Eur Urol. 2014 Feb;65(2):372-7. doi: 10.1016/j.eururo.2013.06.044. Epub 2013 Jul 2.
6
Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Eur Urol. 2013 Oct;64(4):600-6. doi: 10.1016/j.eururo.2012.12.023. Epub 2012 Dec 25.
7
Percutaneous cryoablation of renal tumors: patient selection, technique, and postprocedural imaging.
Radiographics. 2010 Jul-Aug;30(4):887-900. doi: 10.1148/rg.304095134.
8
Chronic kidney disease and mortality risk: a systematic review.
J Am Soc Nephrol. 2006 Jul;17(7):2034-47. doi: 10.1681/ASN.2005101085. Epub 2006 May 31.
9
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
N Engl J Med. 2004 Sep 23;351(13):1296-305. doi: 10.1056/NEJMoa041031.
Zotero 插件